| Members |
targetComponentId |
| Lipoma of spinal column |
Lipoma of spinal cord |
| liposarkom |
Liposarcoma |
| liposomalt daunorubicin 2 mg/ml, injektionsvätska, emulsion |
Product containing only daunorubicin liposome in parenteral dose form (medicinal product form) |
| liposomal doxorubicinhydroklorid 2 mg/ml, infusionskoncentrat, flaska 10 ml |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| liposomal doxorubicinhydroklorid 2 mg/ml, infusionskoncentrat, flaska 25 ml |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Liposuction of subcutaneous tissue NEC |
Liposuction of subcutaneous tissue |
| Liquid paraffin [eye] |
Product containing mineral oil (medicinal product) |
| Liquid paraffin [laxative] |
Product containing mineral oil (medicinal product) |
| liraglutid 6 mg/ml, injektionsvätska, lösning |
Product containing only liraglutide (medicinal product) |
| lisinoprilallergi |
Non-allergic hypersensitivity to lisinopril |
| Listeria murrayi |
Listeria grayi (organism) |
| litiumkarbonat 300 mg, tablett med modifierad frisättning |
Product containing only lithium carbonate in oral dose form (medicinal product form) |
| litiumkarbonat 300 mg, depåtablett |
Product containing only lithium carbonate in oral dose form (medicinal product form) |
| kontroll av litium |
Monitoring of lithium therapy |
| Liveborn with birth asphyxia NOS |
Intrapartum fetal hypoxia |
| livedoid vaskulit i nedre extremitet orsakad av varicer på ben |
Livedoid vasculopathy of lower limb due to varicose veins of lower limb (disorder) |
| fixering med dynamiska drag |
Dynamic splinting |
| fynd som rör TNM-stadium i levern |
American Joint Committee on Cancer allowable value |
| leverabscess förutom leverabscess orsakad av amöba |
Abscess of liver |
| Liver derivative complex 25.5mg injection |
Liver extract only product |
| leverderivatkomplex 25,5 mg/ml + injektionsvätska, lösning, ampull |
Liver extract only product |
| Liver enzymes NOS |
Measurement of liver enzyme |
| Liver enzymes NOS |
Measurement of liver enzyme |
| Living on the street |
Homeless |
| Living organism |
Organism (organism) |
| Living organism category not applicable |
Organism (organism) |
| Living organism not assigned code in SNOMED |
Organism (organism) |
| Living organism not assigned to a scientific category |
Organism (organism) |
| Living organism not identified |
No living organism identified (finding) |
| Lloyd's syndrome |
Autoimmune polyendocrinopathy |
| hummer, livsmedel |
Lobster (substance) |
| lokal förflyttningslambå |
Reconstruction using local advancement flap (procedure) |
| Local convulsion |
Focal onset epileptic seizure |
| Local cyst of bone |
Bone cyst |
| Local fasciocutaneous flap NOS |
Local fasciocutaneous flap |
| Local fasciocutaneous flap to head or neck NEC |
Local fasciocutaneous flap |
| Local flap of skin to head or neck NEC |
Reconstruction with local flap |
| Local flap reconstruction by V-Y advancement - action |
Local flap reconstruction by advancement - action (qualifier value) |
| Local pedicle V-Y flap reconstruction - action |
Local flap reconstruction - action |
| Local pedicle flap reconstruction - action |
Local flap reconstruction - action |
| Local pedicle island flap reconstruction - action |
Local flap reconstruction - action |
| Local sensory skin flap NEC |
Local sensory skin flap (procedure) |
| Local subcutaneous pedicle flap, myocutaneous NEC |
Reconstruction using local subcutaneous pedicle myocutaneous flap |
| Local subcutaneous pedicle island flap to head or neck NEC |
Reconstruction using local subcutaneous pedicle island flap |
| Local subcutaneous pedicle island flap, axial pattern NEC |
Reconstruction using local axial pattern subcutaneous pedicle island flap |
| lokal subkutan stjälkad ölambå till huvud eller hals, kärlsäkrad |
Reconstruction of skin using local subcutaneous pedicle island axial pattern skin flap (procedure) |
| Local subcutaneous pedicle island flap, fasciocutaneous NEC |
Reconstruction using local subcutaneous pedicle fasciocutaneous flap |
| Local subcutaneous pedicle island flap, random pattern NEC |
Reconstruction using local subcutaneous pedicle island random pattern flap (procedure) |
| lokal subkutan stjälkad ölambå till huvud eller hals, icke kärlsäkrad |
Reconstruction of skin using local subcutaneous pedicle island random pattern skin flap (procedure) |
| Local subcutaneous pedicle skin flap NOS |
Reconstruction of skin using local subcutaneous pedicle skin flap (procedure) |
| Local transposition flap, axial pattern NEC |
Local transposition flap - axial pattern |
| Local transposition flap, random pattern NEC |
Local transposition flap - random pattern |
| Localization-related epilepsy |
Focal onset epileptic seizure |
| lokaliserad vuxenparodontit |
Localized chronic periodontitis |
| lokaliserad dermatit orsakad av intagen substans och/eller läkemedel |
Localized dermatitis caused by substance taken via oral route (disorder) |
| Locked twins obstructing labor |
Interlocked twins |
| lomefloxacin 0,3 %, ögondroppar |
Lomefloxacin 3 mg/mL eye solution |
| långt atoniskt anfall |
Atonic epileptic seizure (finding) |
| Long-acting thyroid stimulator |
Thyroid stimulating immunoglobulins |
| Loperamide 2mg oral lyophilisate tablet |
Loperamide hydrochloride 2 mg oral tablet |
| loperamidhydroklorid 1 mg/5 ml, oral sirap |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| loperamidhydroklorid 1 mg/5 ml, sockerfri sirap |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| loperamidhydroklorid 2 mg, munsönderfallande tablett |
Loperamide hydrochloride 2 mg oral tablet |
| Loperamide hydrochloride+simethicone |
Product containing loperamide and simeticone (medicinal product) |
| Lophortyx gambelii |
Callipepla gambelii (organism) |
| lorakarbef 100 mg/5 ml, oral suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef 100mg/5mL suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| lorakarbef 200 mg/5 ml, oral suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef 200mg/5mL suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef, anhydrous 100mg/5mL powder |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef, anhydrous 200mg/5 mL powder |
Loracarbef 40 mg/mL oral suspension |
| loratadin 10 mg/10 ml, sirap |
Loratadine 1 mg/mL oral solution |
| loratadin + pseudoefedrinsulfat 5 mg/120 mg, tablett med modifierad frisättning |
Loratadine and pseudoephedrine only product in oral dose form |
| loratadin 5 mg + pseudoefedrinsulfat 120 mg, depåtablett |
Loratadine and pseudoephedrine only product in oral dose form |
| lordos vid höftsjukdom |
Lordosis deformity of spine due to disorder of hip region |
| lordos vid skelettdysplasi |
Lordosis deformity of spine due to congenital skeletal dysplasia |
| lovastatin 10 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 10 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 20 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 20 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 40 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 40 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 60 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
| lovastatin 60 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Low cervical cesarean section |
Lower uterine segment caesarean section |
| lågt cervikalt kejsarsnitt |
Lower uterine segment caesarean section |
| Low pressure hydrocephalus |
Normal pressure hydrocephalus |
| underbenslambå |
Flap (substance) |
| icke kärlsäkrad underbenslambå |
Random pattern flap |
| lambå på nedre extremiteten |
Flap (substance) |
| Lower uterine segment cesarean delivery NEC |
Lower uterine segment caesarean section |
| smörjmedel |
Automotive lubricant |
| smörjolja |
Automotive lubricating oil (substance) |
| Lucilia sericata |
Phaenicia sericata |
| lumbal diskografi |
Discography with injection of contrast into intervertebral disc of lumbar spine (procedure) |
| lumbal somatisk dysfunktion |
Somatic dysfunction of lumbar region (finding) |
| Lumbar spine DXA scan |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
| Lumbar spine DXA scan |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
| Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
FHIR